The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer-Reference-Cited by-同舟云学术

The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer

Published:2016-09-15 Issue:4 Volume:44 Page:217-222
ISSN:0091-4916
Container-title:Journal of Nuclear Medicine Technology
language:en
Short-container-title:J. Nucl. Med. Technol.

Author:

Kulshrestha Randeep Kumar,Vinjamuri Sobhan,England Andrew,Nightingale Julie,Hogg Peter

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiological and Ultrasound Technology

Reference20 articles.

1. Cancer facts & figures 2010. American Cancer Society website. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/. Accessed October 4, 2016.

2. Edge S Byrd DR Compton CC , eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2010.

3. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography;Schirrmeister;J Clin Oncol.,1999

4. Fluorine-18: a new isotope for bone scanning;Blau;J Nucl Med.,1962

5. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT;Even-Sapir;J Nucl Med.,2004

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micronutrient Status and Breast Cancer: A Narrative Review;International Journal of Molecular Sciences;2024-05-02

2. SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases;Seminars in Nuclear Medicine;2024-05

3. Clinical Positron Emission Tomography/Computed Tomography;PET Clinics;2024-04

4. Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging;Seminars in Nuclear Medicine;2024-01

5. Impact of PET and PET/CT Radiotracer for Evaluating Efficacy of CDK4/6 Inhibitor Therapy in HR-Positive HER2-Negative Metastatic Breast Cancer;IFMBE Proceedings;2024